全文获取类型
收费全文 | 95篇 |
免费 | 8篇 |
专业分类
儿科学 | 31篇 |
基础医学 | 4篇 |
口腔科学 | 2篇 |
临床医学 | 17篇 |
内科学 | 20篇 |
皮肤病学 | 4篇 |
神经病学 | 1篇 |
外科学 | 21篇 |
预防医学 | 2篇 |
药学 | 1篇 |
出版年
2021年 | 1篇 |
2017年 | 1篇 |
2016年 | 3篇 |
2015年 | 4篇 |
2014年 | 1篇 |
2013年 | 10篇 |
2012年 | 2篇 |
2011年 | 1篇 |
2010年 | 6篇 |
2009年 | 8篇 |
2008年 | 1篇 |
2007年 | 8篇 |
2006年 | 15篇 |
2005年 | 2篇 |
2004年 | 4篇 |
2003年 | 2篇 |
2001年 | 2篇 |
2000年 | 1篇 |
1999年 | 5篇 |
1998年 | 7篇 |
1997年 | 5篇 |
1996年 | 5篇 |
1994年 | 2篇 |
1993年 | 2篇 |
1992年 | 1篇 |
1991年 | 1篇 |
1990年 | 1篇 |
1976年 | 1篇 |
1971年 | 1篇 |
排序方式: 共有103条查询结果,搜索用时 0 毫秒
101.
AYSE SAATCI YASAR M.D. EMINE BILEN M.D. MEHMET BILGE M.D. GOKTURK IPEK M.D. EMRAH IPEK M.D. OZGUR KIRBAS M.D. 《Pacing and clinical electrophysiology : PACE》2009,32(9):1168-1172
Background: Metabolic syndrome (MS) has been reported to be associated with an increased risk of atrial fibrillation (AF). The aim of this study was to investigate P-wave dispersion (PWD) in patients with MS.
Methods: The study population included 66 patients with MS (21 men, 45 women; mean age, 49.7 ± 9.1 years) and 63 control subjects without MS (26 men, 37 women; mean age, 47.0 ± 10.6 years). The diagnosis of MS was based on the National Cholesterol Education Program Adult Treatment Panel III criteria. A 12-lead electrocardiogram was recorded for each subject. The difference between maximum and minimum P-wave duration was calculated and defined as PWD. An echocardiographic examination was also performed for each subject.
Results: Maximum P-wave duration and PWD were found to be significantly higher in patients with MS compared with the control subjects (Maximum P-wave duration: 113.5 ± 9.7 ms vs 101.0 ± 8.1 ms, PWD: 37.8 ± 7.6 vs 23.3 ± 5.9, respectively, P < 0.001 for both). However, there was no statistically significant difference between two groups regarding minimum P-wave duration (75.6 ± 6.9 ms vs 77.6 ± 7.8 ms, respectively, P = 0.18). In addition, PWD was positively correlated with age, body mass index, waist circumference, systolic and diastolic blood pressure, triglyceride level, deceleration time, isovolumetric relaxation time and negatively correlated with high-density lipoprotein cholesterol level and early-to-late diastolic velocity ratio .
Conclusion: We have shown that patients with MS have higher PWD, indicating increased risk for AF, compared to the control subjects without MS. 相似文献
Methods: The study population included 66 patients with MS (21 men, 45 women; mean age, 49.7 ± 9.1 years) and 63 control subjects without MS (26 men, 37 women; mean age, 47.0 ± 10.6 years). The diagnosis of MS was based on the National Cholesterol Education Program Adult Treatment Panel III criteria. A 12-lead electrocardiogram was recorded for each subject. The difference between maximum and minimum P-wave duration was calculated and defined as PWD. An echocardiographic examination was also performed for each subject.
Results: Maximum P-wave duration and PWD were found to be significantly higher in patients with MS compared with the control subjects (Maximum P-wave duration: 113.5 ± 9.7 ms vs 101.0 ± 8.1 ms, PWD: 37.8 ± 7.6 vs 23.3 ± 5.9, respectively, P < 0.001 for both). However, there was no statistically significant difference between two groups regarding minimum P-wave duration (75.6 ± 6.9 ms vs 77.6 ± 7.8 ms, respectively, P = 0.18). In addition, PWD was positively correlated with age, body mass index, waist circumference, systolic and diastolic blood pressure, triglyceride level, deceleration time, isovolumetric relaxation time and negatively correlated with high-density lipoprotein cholesterol level and early-to-late diastolic velocity ratio .
Conclusion: We have shown that patients with MS have higher PWD, indicating increased risk for AF, compared to the control subjects without MS. 相似文献
102.
SAVA DEMIRBILEK ABDURRAHMAN KARAMAN AYSUN BAYKARABULUT MELIH AKN KUBILAY GÜRÜNLÜOLU EMINE TÜRKMEN ERKAN TA RAUF TURUL AKSOY MEHMET NACI EDAL 《International journal of urology》2006,13(6):747-753
AIM: Polyenylphosphatidycholine has been demonstrated to have antioxidant, cytoprotective and anti-inflammatory effects. Whether polyenylphosphatidycholine pretreatment affects ischemia/reperfusion-induced renal damage in vivo is not known and was investigated here in rats. METHODS: Forty female Sprague-Dawley rats were divided into three groups. Group 1 (n = 10) was given saline (control, sham operated). Group 2 (n = 15) were given saline, and Group 3 (n = 15) were given polyenylphosphatidycholine (100 mg/day for 10 days prior to experiment). Groups 2 and 3 were subjected to bilateral renal ischemia (60 min) followed by reperfusion (6 h). After the reperfusion period, the rats were sacrificed and kidney tissue superoxide dismutase, glutathione, total nitrite and nitrate, malondialdehyde and myeloperoxidase levels, plasma aspartate aminotransferase, blood urea nitrogen and creatinine concentrations, and nuclear factor kappa beta expression were determined. RESULTS: Serum levels of aspartate aminotransferase, blood urea nitrogen and creatinine were significantly decreased (P < 0.05) in the treatment group compared to those in the ischemic group. There were significant differences between treatment and ischemic groups regarding the tissue superoxide dismutase, glutathione, total nitrite and nitrate, malondialdehyde, and myeloperoxidase levels (P < 0.05). In addition, polyenylphosphatidycholine pretreatment reduced nuclear factor kappa beta expression in ischemic kidney tissue. Kidneys obtained from rats pretreated with polyenylphosphatidycholine demonstrated marked reduction of the histological features of renal injury compared to kidneys obtained from Group 2 rats, including a little vacuolization, pyknosis and necrosis. CONCLUSIONS: Polyenylphosphatidycholine pretreatment provided significant protection against ischemia/reperfusion injury to the kidney. This treatment could be therapeutic in kidney transplantation and other conditions associated with ischemia/reperfusion injury to the kidney. 相似文献
103.